Structure Therapeutics Inc.
GPCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $109 | $70 | $36 | $29 |
| G&A Expenses | $49 | $33 | $16 | $9 |
| SG&A Expenses | $49 | $33 | $16 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $158 | $103 | $53 | $38 |
| Operating Income | -$158 | -$103 | -$53 | -$38 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $36 | $13 | $1 | -$0 |
| Pre-Tax Income | -$122 | -$89 | -$51 | -$38 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$123 | -$90 | -$51 | -$40 |
| % Margin | – | – | – | – |
| EPS | -2.34 | -2.43 | -1.44 | -1.2 |
| % Growth | 3.7% | -68.8% | -20% | – |
| EPS Diluted | -2.34 | -2.43 | -1.44 | -1.2 |
| Weighted Avg Shares Out | 53 | 37 | 37 | 37 |
| Weighted Avg Shares Out Dil | 53 | 37 | 37 | 37 |
| Supplemental Information | – | – | – | – |
| Interest Income | $36 | $13 | $1 | $0 |
| Interest Expense | $0 | $13 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | -$157 | -$102 | -$52 | -$38 |
| % Margin | – | – | – | – |